
Keywords: Drug delivery; PLGA-PEG; Cisplatin prodrugs; Docetaxel; Combination therapy; AST; aspartate aminotransferase; ALT; alanine aminotransferase; BUN; blood urea nitrogen; C4CP; butyrate modified Pt(IV); C8CP; octanoate modified Pt(IV); C10CP; decanoate modi